09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IV.<br />

DERIVATION OF CANCER POTENCY<br />

Basis for Cancer Potency<br />

Two studies, Innes et al. (1969) and NCI (1979), have been deemed adequate for the derivation of<br />

cancer potencies. Both demonstrate statistically significant increases in tumor incidence among 2,4,6-<br />

trichlorophenol exposed animal populations. Innes et al. (1969) show increased incidence of reticulum<br />

cell sarcomas in male B6C3F 1 mice and heptomas in female B6C3F 1 mice. The NCI (1979) study<br />

shows increased incidence of hepatomas in both male and female B6C3F 1 mice, and leukemia in male<br />

Fischer F344 rats. The US EPA estimate of cancer potency of 2,4,6-trichlorophenol derived from the<br />

rat study is lower than that for mice (US EPA, 1988 and below). Since selection of the potency value is<br />

made on the basis of the most sensitive species, site, and study in the absence of evidence that the data<br />

are not representative, tumor induction in B6C3F 1 mice has been chosen as the basis for derivation of a<br />

cancer potency value for 2,4,6-trichlorophenol.<br />

Methodology<br />

The multistage Doll-Armitage model polynomial was fit to tumor incidence data from Innes et al.(1969)<br />

and NCI (1979) (Armitage and Doll, 1954). Dosage estimates for the studies were based on food<br />

intake assumptions of 12% and 13% of body weight for male and female mice, respectively (Gold,<br />

1984). In the NCI (1979) study, final dose values were calculated to be 1200 and 600 mg/kg-day for<br />

high- and low-dose females, and 1356 and 678 mg/kg-day for high- and low-dose males. In the Innes<br />

et al.(1969) study, dosage estimates were based on the method of Crouch to account for variation in<br />

dosing during the course of the experiment (Crouch, 1983). Dosage estimates were calculated to be<br />

32.5 and 34.7 mg/kg-day for male and female mice, respectively. Using a multistage polynomial, the<br />

cancer potency was derived using the probability of dying with a tumor from a given dose and the<br />

background lifetime cancer incidence (Crump and Howe, 1984). The upper 95% confidence bound on<br />

the cancer potency was termed q * 1 . Estimates of q * 1 for tumor induction in B6C3F 1 mice are<br />

presented in Table 4.<br />

*<br />

Calculation of the cancer potency in animals (q animal ) can be made using q 1 and the following<br />

relationship, where T is the natural lifespan of the animal (104 weeks) and T e is the experimental<br />

duration (Innes et al., T e = 104 weeks; NCI, T e = 78 weeks):<br />

q animal = q 1 * × (T/T e ) 3<br />

The resulting q animal can be converted to human cancer potency (q human ) based on the following<br />

relationship, where bw animal is the assumed body weight for the test species (Innes et al. (1969),<br />

bw animal = 0.030 kg; NCI (1979), bw animal = 0.04 kg-males and 0.035 kg-females) and bw human is the<br />

assumed human body weight (70 kg):<br />

q human = q animal × (bw h /bw a ) 1/3<br />

534

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!